Company: Orgenesis Inc.
Job title: Senior Director of Advanced Therapies
Decentralized Approach to Autologous Cell Therapy Manufacturing – Advantages of Harmonized TILs Manufacturing at a Point of Care 9:30 am
• Maintaining high quality by harmonized approach at decentralized Point of Care • Increasing TIL therapy accessibility using mobile processing units for global deployment and scale out • Developing a closed system for TIL manufacturing at point of care to both reduce contamination risk and production costRead more
day: Day Two